Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Intuitive Surgical, Inc. (ISRG) -- Ignore unavailable to you. Want to Upgrade?

To: IceHawk who wrote (322)	11/15/2017 10:21:32 PM
From: semi_infinite	Read Replies (1) \| Respond to of 438

You asked for my comments and I answered. The article is just poorly researched and when the MAIN quoted source refutes the way the article characterized an "interview", there is a major problem isn't there? Besides, there are major discrepancies between what the article states about EU marketing and what the TRXC stated goals were when they bought ALF. It is not hard to find out what TRXC was trying to achieve as their presentations are archived. And it looks they got it done and achieved those goals on time with regards to Senhance clinical data, reference centers and FDA clearance. ISRG is a great company and they will be facing competition from TRXC if not imminently, then surely when articulated instruments get released. BOL to you.